Product Images Aurovela Fe 1/20

This is a table that shows circulatory disease mortality rates per 100,000 woman years categorized under age groups, smoking status, and oral contraceptive use. There are mortality rates for ever-users (non-smokers) and controls (non-smokers) as well as ever-users (smokers) and controls (smokers). The mortality rates are presented in numbers of deaths per 100,000 woman user, and are shown on a scale of 0-250. The age groups presented in the table are 15-24, 25-34, and 35-44. This table is adapted from a reference by P.M. Laydeand and V. Beral.*

This text provides a list of studies related to the use of combined oral contraceptives (COCs) and their effect on women's health. It includes information on the results of each study, presented as odds ratios or risk ratios. The studies compare women who have ever used COCs to those who have never used them, and current COC users to those who have never used them. The text may be useful for researchers or healthcare professionals who are interested in the safety and effectiveness of COCs.*

This is a set of instructions related to the start of taking birth control pills. It explains the labels and strips to be used depending on whether a person starts their period on Sunday or any other day of the week. The given text further provides a weekly calendar-like layout to help in keeping track of daily pills intake. The annotation also suggests taking pills from left to right for each week.*

This appears to be a set of instructions for a birth control pill packet. The packaging includes labels for each day of the week, as well as three weeks of pills and one week labeled "Week 4" with no pills. The first page provides instructions for those whose periods start on a day other than Sunday. The rest of the text appears to provide more general instructions for taking the pills.*

Aurovela Fe 1/20 is a 28-day regimen medication containing norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets. It comes in a pouch consisting of 21 light yellow to yellow tablets and seven brown tablets. The medication is intended to prevent pregnancy but does not protect against HIV or other sexually transmitted diseases. Store at 20 to 25 degrees Celsius, and keep this medication out of children's reach. Pharmacies may apply a label.*

Vela Fe 1/20 is a pack of oral contraceptive tablets in blister packs. The package contains 5 blister packs, each consisting of 28 tablets. Each blister pack contains seven brown tablets and 21 light yellow to yellow tablets. The brown tablets consist of ferrous fumarate USP, 75 mg, which is not USP for dissolution and assay. The light yellow tablets contain norethindrone acetate USP, 1 mg, and ethinyl estradiol USP, 20 mcg. The product is intended to prevent pregnancy only and does not protect against sexually transmitted diseases. The tablets are not USP for dissolution and assay. The product is distributed by Aurobindo Pharma USA, Inc. Keep the package out of reach of children and store at room temperature.*